JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
CRSP - Crispr Therapeutics AG
USD | NASDAQ | Healthcare
Summary
Summary CRSP Stock
Financials
Financials CRSP Stock
Loading...
Loading...
Income Statement
Income Statement CRSP Stock
Balance Sheet
Balance Sheet CRSP Stock
Cash Flow Statement
Cash Flow Statement CRSP Stock
Loading...
Loading...
CRSP Financials - Crispr Therapeutics Income & Cash Flow | Ledgeburg
Home
Stocks
Crispr Therapeutics AG (CRSP)
Financials
Financials of CRSP
Loading...
Loading...
Loading...
Loading...
Revenue
$3.51M
Operating Income
$-664.571M
Net Income
$-581.599M
Share Count (Basic)
89.925109M
Operating Cash Flow
$-345.014M
Free Cash Flow
$-345.928M
Cash And Short-Term Equivalents
$1.975828B
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
200M
400M
600M
800M
1B
FY2021
FY2022
FY2023
FY2024
Revenue $USD
0
500K
1M
1.5M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-600M
-400M
-200M
0
200M
400M
Annual
Quarterly
Margins
Gross
Operating
Net
-60000%
-40000%
-20000%
0%
FY2025
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-200M
-180M
-160M
-140M
-120M
-100M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-25000%
-20000%
-15000%
-10000%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26